1 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D00150
D00150
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
2 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D00400
D00400
|
Valsartan
| 7件: 57 57, 58, 66, 75, 218, 222, 224 |
3 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D00522
D00522
|
Candesartan
| 2件: 58 58, 67 |
4 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D00523
D00523
|
Irbesartan
| 4件: 66 66, 167, 168, 222 |
5 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D00626
D00626
|
Candesartan cilexetil
| 1件: 67 67 |
6 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D00627
D00627
|
Telmisartan
| 2件: 66 66, 67 |
7 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D02014
D02014
|
Angiotensin II
| 7件: 17 17, 19, 46, 66, 86, 222, 224 |
8 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D08146
D08146
|
Losartan
| 17件: 17 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
9 |
AGTR1
| 4件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion | D11776
D11776
|
Sparsentan
| 3件: 66 66, 218, 222 |
10 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D01977
D01977
|
Gefitinib
| 1件: 75 75 |
11 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D03455
D03455
|
Cetuximab
| 2件: 51 51, 86 |
12 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D07907
D07907
|
Erlotinib
| 1件: 94 94 |
13 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
14 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D08950
D08950
|
Neratinib
| 1件: 34 34 |
15 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D11251
D11251
|
Icotinib
| 1件: 34 34 |
16 |
EGFR
| 9件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Proteoglycans in cancer, Prostate cancer | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
17 |
F2
| 3件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton | D06410
D06410
|
Thrombomodulin Alfa
| 1件: 85 85 |
18 |
F2
| 3件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton | D07144
D07144
|
Dabigatran etexilate
| 2件: 51 51, 75 |
19 |
F2
| 3件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton | D09707
D09707
|
Dabigatran
| 5件: 51 51, 75, 85, 91, 124 |
20 |
FCER1A
| 2件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway | D05251
D05251
|
Omalizumab
| 7件: 46 46, 53, 65, 98, 162, 226, 299 |
21 |
MTOR
| 10件: Phospholipase D signaling pathway Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer | D00753
D00753
|
Sirolimus
| 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 |
22 |
MTOR
| 10件: Phospholipase D signaling pathway Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer | D02714
D02714
|
Everolimus
| 9件: 34 34, 67, 89, 96, 137, 157, 158, 228, 277 |
23 |
MTOR
| 10件: Phospholipase D signaling pathway Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Proteoglycans in cancer, Prostate cancer | D06068
D06068
|
Temsirolimus
| 1件: 13 13 |
24 |
FYN
| 6件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Platelet activation, T cell receptor signaling pathway, Prion disease, Viral myocarditis | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
25 |
FYN
| 6件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Platelet activation, T cell receptor signaling pathway, Prion disease, Viral myocarditis | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
26 |
CXCR1
| 2件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Phospholipase D signaling pathway | D08984
D08984
|
Reparixin
| 2件: 298 298, 299 |
27 |
CXCR2
| 2件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Phospholipase D signaling pathway | D08984
D08984
|
Reparixin
| 2件: 298 298, 299 |
28 |
INSR
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus | D03230
D03230
|
Insulin human
| 2件: 96 96, 156 |
29 |
INSR
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus | D03250
D03250
|
Insulin glargine
| 1件: 299 299 |
30 |
INSR
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus | D04539
D04539
|
Insulin detemir
| 1件: 299 299 |
31 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
32 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
33 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D08066
D08066
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
34 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
35 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
36 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
37 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D10229
D10229
|
Masitinib
| 6件: 2 2, 5, 6, 13, 46, 96 |
38 |
KIT
| 4件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway | D11270
D11270
|
Pexidartinib
| 1件: 34 34 |
39 |
PDGFRA
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08066
D08066
|
Imatinib
| 12件: 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
40 |
PDGFRA
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
41 |
PDGFRA
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
42 |
PDGFRA
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
43 |
PDGFRB
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
44 |
PDGFRB
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
45 |
PDGFRB
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
46 |
PDGFRB
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08552
D08552
|
Sunitinib
| 2件: 28 28, 34 |
47 |
PDGFRB
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D08953
D08953
|
Nilotinib
| 5件: 6 6, 8, 34, 51, 86 |
48 |
PDGFRB
| 6件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Prostate cancer | D10481
D10481
|
Nintedanib
| 5件: 51 51, 85, 89, 227, 228 |
49 |
PIK3CA
| 29件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
50 |
PIK3CA
| 29件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
51 |
PIK3CB
| 29件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
52 |
PIK3CD
| 29件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
53 |
PIK3CD
| 29件: Platinum drug resistance Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
54 |
AVPR1A
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction | D00101
D00101
|
Vasopressin
| 1件: 210 210 |
55 |
AVPR1A
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction | D06672
D06672
|
Terlipressin
| 1件: 299 299 |
56 |
AVPR1A
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction | D07748
D07748
|
Conivaptan
| 1件: 86 86 |
57 |
AVPR1B
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction | D00101
D00101
|
Vasopressin
| 1件: 210 210 |
58 |
AVPR1B
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vascular smooth muscle contraction | D06672
D06672
|
Terlipressin
| 1件: 299 299 |
59 |
AVPR2
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | D00101
D00101
|
Vasopressin
| 1件: 210 210 |
60 |
AVPR2
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | D00291
D00291
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 |
61 |
AVPR2
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | D01213
D01213
|
Tolvaptan
| 4件: 67 67, 72, 86, 225 |
62 |
AVPR2
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | D04752
D04752
|
Lixivaptan
| 1件: 67 67 |
63 |
AVPR2
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | D06672
D06672
|
Terlipressin
| 1件: 299 299 |
64 |
AVPR2
| 2件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption | D07748
D07748
|
Conivaptan
| 1件: 86 86 |
65 |
MAP2K1
| 23件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
66 |
MAP2K1
| 23件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
67 |
MAP2K1
| 23件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
68 |
MAP2K1
| 23件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
69 |
MAP2K1
| 23件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
70 |
MAP2K2
| 20件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
71 |
MAP2K2
| 20件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
72 |
MAP2K2
| 20件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
73 |
MAP2K2
| 20件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
74 |
MAP2K2
| 20件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Yersinia infection, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
75 |
PTGFR
| 1件: Phospholipase D signaling pathway Phospholipase D signaling pathway | D06274
D06274
|
Tafluprost
| 1件: 299 299 |
76 |
PTGFR
| 1件: Phospholipase D signaling pathway Phospholipase D signaling pathway | D08661
D08661
|
Unoprostone
| 1件: 90 90 |
77 |
RAF1
| 20件: Ras signaling pathway Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Salmonella infection, Tuberculosis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
78 |
SYK
| 5件: Phospholipase D signaling pathway Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis | D09347
D09347
|
Fostamatinib
| 4件: 46 46, 49, 61, 66 |